Search

Your search keyword '"Harbst, Katja"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Harbst, Katja" Remove constraint Author: "Harbst, Katja"
82 results on '"Harbst, Katja"'

Search Results

51. Additional file 9 of Exploring the link between MORF4L1 and risk of breast cancer

52. Additional file of Exploring the link between MORF4L1 and risk of breast cancer

53. Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma

55. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

57. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

58. Exploring the link between MORF4L1 and risk of breast cancer

59. The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

60. Tumor genetic heterogeneity analysis of chronic sun‐damaged melanoma.

61. Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

62. NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics

63. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

64. Additional file 1: Figure S1. of DNA methylation subgroups in melanoma are associated with proliferative and immunological processes

65. Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma

67. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

68. Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

69. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

70. Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy

71. Primary Melanoma Tumors from CDKN2A Mutation Carriers Do Not Belong to a Distinct Molecular Subclass

72. Immune escape mechanisms associated with tumor recurrence after adoptive cell transfer immunotherapy.

73. Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study

75. Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

78. Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148

79. Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8 + T Cells in Non-Melanoma Cancers Compared to Melanoma.

80. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

81. CTLA-4 blockade boosts the expansion of tumor-reactive CD8 + tumor-infiltrating lymphocytes in ovarian cancer.

82. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.

Catalog

Books, media, physical & digital resources